Date: 26-May-2021 Protocol Number: CD15_COVID-19
Post# of 155130
(Total Views: 316)
Posted On: 07/15/2025 1:02:37 AM
Date: 26-May-2021
Protocol Number: CD15_COVID-19
Version: 5.0
That is the Long Hauler 190 page protocol.
Page 68:
8.2.3. Exploratory Outcome Measures (Endpoints)
*Change from baseline in CD4+ and CD8+ T cell count on Days 28 and 56
_____
Jumo to the Long Hauler trial in florida:
Change From Baseline in CD4+ and CD8+ T Cell Count on Days 28 and 56.
We did not report the CD4+ and CD8+ T Cells in the LH trial final results.
Due to being Exploratory ?
Why create the CCR5 RO Assay, & not use it in the LH trial ?
My bet is the obvious:
They did & post Amarex settlement, now also have the CD4+ T cells data of Baseline to days 28 & 56.
No press releases due to still waiting on RECOVER-LC acceptance / rejection decision.
Either way, Cytodyn has a CCR5 RO Assay to measure CD4+ T Cells in any applicable trial....
https://clinicaltrials.gov/study/NCT04678830
https://pmc.ncbi.nlm.nih.gov/articles/PMC8640501/
Protocol Number: CD15_COVID-19
Version: 5.0
That is the Long Hauler 190 page protocol.
Page 68:
8.2.3. Exploratory Outcome Measures (Endpoints)
*Change from baseline in CD4+ and CD8+ T cell count on Days 28 and 56
_____
Jumo to the Long Hauler trial in florida:
Change From Baseline in CD4+ and CD8+ T Cell Count on Days 28 and 56.
We did not report the CD4+ and CD8+ T Cells in the LH trial final results.
Due to being Exploratory ?
Why create the CCR5 RO Assay, & not use it in the LH trial ?
My bet is the obvious:
They did & post Amarex settlement, now also have the CD4+ T cells data of Baseline to days 28 & 56.
No press releases due to still waiting on RECOVER-LC acceptance / rejection decision.
Either way, Cytodyn has a CCR5 RO Assay to measure CD4+ T Cells in any applicable trial....
https://clinicaltrials.gov/study/NCT04678830
https://pmc.ncbi.nlm.nih.gov/articles/PMC8640501/
(2)
(0)